Drug data last refreshed 10h ago · AI intelligence enriched 3w ago
Soma Compound with Codeine is a fixed-dose combination tablet containing aspirin (analgesic), carisoprodol (muscle relaxant), and codeine phosphate (opioid analgesic). It is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. The combination works through complementary mechanisms: aspirin reduces inflammation, carisoprodol relaxes skeletal muscles, and codeine provides opioid-mediated analgesia.
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30/100), commercial teams face defensive strategy and potential downsizing.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Soma Compound with Codeine offers limited career growth prospects given its LOE-approaching status and zero linked job openings. Professionals on this portfolio should prepare for transition to higher-growth assets or consider roles focused on managed care and generic transition strategy.
Worked on SOMA COMPOUND W/ CODEINE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.